Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City

J Clin Invest. 2020 Sep 1;130(9):4522-4524. doi: 10.1172/JCI142151.

Authors

Roy M Gulick¹, Magdalena E Sobieszczyk², Donald W Landry², Anthony N Hollenberg¹

Affiliations

¹ Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
² Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Betacoronavirus*
COVID-19
COVID-19 Serotherapy
Clinical Protocols
Coronavirus Infections / epidemiology*
Coronavirus Infections / therapy*
Humans
Immunization, Passive
Immunologic Factors / therapeutic use
New York City / epidemiology
Pandemics*
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / therapy*
Randomized Controlled Trials as Topic
SARS-CoV-2
Safety

Substances

Antiviral Agents
Immunologic Factors